124 related articles for article (PubMed ID: 27121912)
1. Speeding up pyrogenicity testing: Identification of suitable cell components and readout parameters for an accelerated monocyte activation test (MAT).
Stoppelkamp S; Würschum N; Stang K; Löder J; Avci-Adali M; Toliashvili L; Schlensak C; Wendel HP; Fennrich S
Drug Test Anal; 2017 Feb; 9(2):260-273. PubMed ID: 27121912
[TBL] [Abstract][Full Text] [Related]
2. An improved monocyte activation test using cryopreserved pooled human mononuclear cells.
Solati S; Aarden L; Zeerleder S; Wouters D
Innate Immun; 2015 Oct; 21(7):677-84. PubMed ID: 25907070
[TBL] [Abstract][Full Text] [Related]
3. Optimization of the monocyte activation test for evaluating pyrogenicity of tick-borne encephalitis virus vaccine.
Etna MP; Giacomini E; Rizzo F; Severa M; Ricci D; Shaid S; Lambrigts D; Valentini S; Galli Stampino L; Alleri L; Gaggioli A; Von Hunolstein C; Spreitzer I; Coccia EM
ALTEX; 2020; 37(4):532-544. PubMed ID: 32488289
[TBL] [Abstract][Full Text] [Related]
4. A rapid 'one-plate' in vitro test for pyrogens.
Poole S; Mistry Y; Ball C; Gaines Das RE; Opie LP; Tucker G; Patel M
J Immunol Methods; 2003 Mar; 274(1-2):209-20. PubMed ID: 12609546
[TBL] [Abstract][Full Text] [Related]
5. Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations.
Valentini S; Santoro G; Baffetta F; Franceschi S; Paludi M; Brandini E; Gherardini L; Serruto D; Capecchi B
Vaccine; 2019 Jun; 37(29):3754-3760. PubMed ID: 30448065
[TBL] [Abstract][Full Text] [Related]
6. Material-mediated pyrogens in medical devices: Applicability of the in vitro Monocyte Activation Test.
Borton LK; Coleman KP
ALTEX; 2018; 35(4):453-463. PubMed ID: 29901209
[TBL] [Abstract][Full Text] [Related]
7. Assessment of pyrogenic response of lipoteichoic acid by the monocyte activation test and the rabbit pyrogen test.
Gimenes I; Caldeira C; Presgrave OA; de Moura WC; Villas Boas MH
Regul Toxicol Pharmacol; 2015 Oct; 73(1):356-60. PubMed ID: 26232706
[TBL] [Abstract][Full Text] [Related]
8. Highly sensitive pyrogen detection on medical devices by the monocyte activation test.
Stang K; Fennrich S; Krajewski S; Stoppelkamp S; Burgener IA; Wendel HP; Post M
J Mater Sci Mater Med; 2014 Apr; 25(4):1065-75. PubMed ID: 24414113
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the in vitro pyrogen test system based on proinflammatory cytokine release from human monocytes: comparison with a human whole blood culture test system and with the rabbit pyrogen test.
Nakagawa Y; Maeda H; Murai T
Clin Diagn Lab Immunol; 2002 May; 9(3):588-97. PubMed ID: 11986265
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test.
Hasiwa N; Daneshian M; Bruegger P; Fennrich S; Hochadel A; Hoffmann S; Rivera-Mariani FE; Rockel C; Schindler S; Spreitzer I; Stoppelkamp S; Vysyaraju K; Hartung T
ALTEX; 2013; 30(2):169-208. PubMed ID: 23665806
[TBL] [Abstract][Full Text] [Related]
11. Determination of Interference During In Vitro Pyrogen Detection: Development and Characterization of a Cell-Based Assay.
Palma L; Rossetti F; Dominici S; Buondelmonte C; Rocchi MB; Rizzardi GP; Vallanti G; Magnani M
Assay Drug Dev Technol; 2017; 15(2):64-76. PubMed ID: 27996302
[TBL] [Abstract][Full Text] [Related]
12. The monocyte activation test detects potentiated cytokine release resulting from the synergistic effect of endotoxin and non-endotoxin pyrogens.
Solati S; Zhang T; Timman S
Innate Immun; 2022 Apr; 28(3-4):130-137. PubMed ID: 35491666
[TBL] [Abstract][Full Text] [Related]
13. Applicability of the Monocyte Activation Test (MAT) in the quality control of the 17DD yellow fever vaccine.
de Mattos KA; Navega ECA; Silva VF; Almeida AS; da Silva CC; Presgrave OAF; Junior DDSG; Delgado IF
Altern Lab Anim; 2018 Mar; 46(1):23-37. PubMed ID: 29553795
[TBL] [Abstract][Full Text] [Related]
14. Applicability of the Monocyte Activation Test (MAT) for hyperimmune sera in the routine of the quality control laboratory: Comparison with the Rabbit Pyrogen Test (RPT).
da Silva CC; Presgrave OA; Hartung T; de Moraes AM; Delgado IF
Toxicol In Vitro; 2016 Apr; 32():70-5. PubMed ID: 26688320
[TBL] [Abstract][Full Text] [Related]
15. Monocyte activation test (MAT) reliably detects pyrogens in parenteral formulations of human serum albumin.
Perdomo-Morales R; Pardo-Ruiz Z; Spreitzer I; Lagarto A; Montag T
ALTEX; 2011; 28(3):227-35. PubMed ID: 21993958
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the monocyte activation test for the safety testing of meningococcal B vaccine Bexsero: A collaborative study.
Studholme L; Sutherland J; Desai T; Hockley J; Care R; Nordgren IK; Vipond C;
Vaccine; 2019 Jun; 37(29):3761-3769. PubMed ID: 31202504
[TBL] [Abstract][Full Text] [Related]
17. Soluble β-(1,3)-glucans enhance LPS-induced response in the monocyte activation test, but inhibit LPS-mediated febrile response in rabbits: Implications for pyrogenicity tests.
Pardo-Ruiz Z; Menéndez-Sardiñas DE; Pacios-Michelena A; Gabilondo-Ramírez T; Montero-Alejo V; Perdomo-Morales R
Eur J Pharm Sci; 2016 Jan; 81():18-26. PubMed ID: 26428698
[TBL] [Abstract][Full Text] [Related]
18. Assay of pyrogens by interleukin-6 release from monocytic cell lines.
Taktak YS; Selkirk S; Bristow AF; Carpenter A; Ball C; Rafferty B; Poole S
J Pharm Pharmacol; 1991 Aug; 43(8):578-82. PubMed ID: 1681074
[TBL] [Abstract][Full Text] [Related]
19. Leukoreduction system chambers provide a valuable source of functional monocytes for the monocyte activation test by comparison with internationally validated methods.
Nordgren IK
J Immunol Methods; 2016 Jan; 428():42-9. PubMed ID: 26678159
[TBL] [Abstract][Full Text] [Related]
20. Validation of the monocyte activation test with three therapeutic monoclonal antibodies.
Daniels R; Van der Elst W; Dieltjens N; Appels T; So CK; Nys T; Voeten L; Breugelmans P; Molenaar-de Backer MWA; Gitz E; Poole S; Patel M
ALTEX; 2022; 39(4):621–635. PubMed ID: 35502618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
